Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Antisense oligonucleotide-based drug development for Cyst... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation
0
Authors
Yifat Oren
17 more
Yifat Oren
•
Ofra Barchad-Avitzur
15 more
•
Batsheva Kerem
Published
February 14, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Genetics And Genomics
Chemistry
Medicine
Rna Splicing
Show all topics
DOI
10.1101/2021.02.14.431123
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Genetics And Genomics
Chemistry
Medicine
Rna Splicing
Show all topics
DOI
10.1101/2021.02.14.431123
License
CC-BY-NC-ND
Other Formats
PDF